MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 275 filers reported holding MYRIAD GENETICS INC in Q4 2013. The put-call ratio across all filers is 4.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,210,792 | -11.2% | 90,384 | -22.6% | 0.00% | -33.3% |
Q1 2024 | $2,488,960 | +213.5% | 116,743 | +241.6% | 0.00% | +200.0% |
Q1 2023 | $793,908 | +55.4% | 34,176 | +27.7% | 0.00% | 0.0% |
Q3 2022 | $511,000 | +20.0% | 26,760 | +14.1% | 0.00% | 0.0% |
Q2 2022 | $426,000 | -43.9% | 23,453 | -22.2% | 0.00% | 0.0% |
Q1 2022 | $760,000 | -66.8% | 30,156 | -63.7% | 0.00% | -50.0% |
Q4 2021 | $2,292,000 | +501.6% | 83,049 | +523.6% | 0.00% | +100.0% |
Q3 2019 | $381,000 | -41.2% | 13,318 | -31.8% | 0.00% | 0.0% |
Q1 2019 | $648,000 | -55.1% | 19,532 | -60.6% | 0.00% | -66.7% |
Q4 2018 | $1,442,000 | -64.0% | 49,609 | -43.0% | 0.00% | -57.1% |
Q3 2018 | $4,006,000 | +714.2% | 87,093 | +562.0% | 0.01% | +600.0% |
Q2 2018 | $492,000 | -55.0% | 13,157 | -64.5% | 0.00% | -66.7% |
Q1 2018 | $1,094,000 | +156.8% | 37,011 | +214.2% | 0.00% | +200.0% |
Q3 2017 | $426,000 | -99.1% | 11,780 | -99.4% | 0.00% | -99.2% |
Q2 2017 | $47,565,000 | +29.2% | 1,840,742 | -4.0% | 0.13% | +24.5% |
Q1 2017 | $36,829,000 | +52.4% | 1,918,172 | +32.3% | 0.10% | +41.7% |
Q4 2016 | $24,163,000 | +34.8% | 1,449,519 | +66.5% | 0.07% | +35.8% |
Q3 2016 | $17,919,000 | -21.0% | 870,708 | +17.5% | 0.05% | -25.4% |
Q2 2016 | $22,674,000 | -19.9% | 740,976 | -2.1% | 0.07% | -22.0% |
Q1 2016 | $28,316,000 | -75.2% | 756,513 | -71.4% | 0.09% | -69.3% |
Q4 2015 | $114,036,000 | -17.3% | 2,642,163 | -28.2% | 0.30% | -26.0% |
Q3 2015 | $137,911,000 | -6.1% | 3,679,579 | -14.9% | 0.40% | +5.0% |
Q2 2015 | $146,888,000 | +24.7% | 4,321,509 | +29.9% | 0.38% | +10.1% |
Q1 2015 | $117,749,000 | +20.2% | 3,326,239 | +15.6% | 0.35% | +4.8% |
Q4 2014 | $97,971,000 | -17.5% | 2,876,422 | -6.5% | 0.33% | -29.3% |
Q3 2014 | $118,715,000 | +7.2% | 3,077,909 | +8.1% | 0.47% | +1.5% |
Q2 2014 | $110,768,000 | +39.2% | 2,846,052 | +22.3% | 0.46% | +31.4% |
Q1 2014 | $79,554,000 | +111.8% | 2,326,835 | +30.0% | 0.35% | +92.3% |
Q4 2013 | $37,558,000 | +7.2% | 1,790,202 | +20.1% | 0.18% | -4.2% |
Q3 2013 | $35,035,000 | +51.9% | 1,490,868 | +73.7% | 0.19% | +26.7% |
Q2 2013 | $23,065,000 | – | 858,374 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |